[Best_Wordpress_Gallery id=”32″ gal_title=”2019″]
2018
Moments in 2018 [Best_Wordpress_Gallery id=”24″ gal_title=”2018″]
Press Statement: PREVENT FOR THE FUTURE: WHY VACCINES MATTER
Vaccinating girls before they are exposed to HPV is a priority and should be accelerated. Vaccination can prevent over 90% of cervical cancer cases. [Best_Wordpress_Gallery id=”18″ gal_title=”Africa Vaccination Week Prevent Now for Future”]
PALLIATIVE CARE POLICY 2021 – 2030
Palliative Care Policy 2021 – 2030 FINAL
The African Medicines Agency: What it means for you
NCDAK, and other founding members of AMATA, representing patients, academia, civil society, and industry, welcome the official ratification of the AMA Treaty, which has enabled the African Medicines Agency to effectively enter into force today. We now call on the African Union to build on the current momentum gained with the legal deposition of instrument of ratification of the Treaty by the minimum required 15 AU Member States, to prepare for the practical implementation of the Agency. [Best_Wordpress_Gallery id=”36″ gal_title=”AMA Joint Statement by the AMA Treaty Alliance Nov 5 2021″] Why AMA, Now? The fragile health systems in Africa are under-resourced, with limited infrastructure and capacity to address the increasing burden of NCDs. The COVID-19 pandemic has demonstrated that health security will only be achieved through concerted efforts and cross-border collaboration, highlighting the importance of having strong regulatory systems in place to enable for patient access to safe, effective and high-quality medicines and vaccines. [Best_Wordpress_Gallery id=”38″ gal_title=”AMA Byte by Dr Zipporah Ali”] Why NCDs stand to benefit Improved access to safe and affordable quality NCD medicines through pooled procurement. Increased financing to NCDs to deal with the growing burden of NCDs through consolidation of funds. Access for equitable distribution of health services for all through the delivery of care i.e. UHC. Regulation and control of sub-standard or falsified medicines through enforcement. Increased advocacy towards NCDs through political support and partnership. Streamlining regulatory assessment process for new drug applications. The AMA will ensure harmonised and strengthened regulatory systems for improved access to safe and affordable quality medicines in Africa essential for universal health coverage.
Appointment of Executive Director
The Board of Directors of The NCD Alliance Kenya (NCDAK) is pleased to announce the appointment of Dr Catherine Karekezi as the Executive Director designate of the organisation with effect from 1st October 2021. Dr Karekezi is a pharmacist by profession with a PhD specialization in Medicinal Chemistry, holds key positions in the non-communicable diseases (NCDs) arena as a Member of the Board and Research Committee East African Non-Communicable Diseases Alliance and a founder Director of Kenya Diabetes Management and Information Centre. She also serves as a Member of the NCD Child Task Force on Essential Medicines and previously as a Member of Steering Group Community of Practice (CoP) for the Meaningful Involvement of People Living with NCDs hosted by the WHO Global Coordination Mechanism on the prevention and control of NCDs (WHO GCM/NCDs). She contributes to NCD prevention, access to treatment and care, health systems strengthening, research, advocacy, and policy development in the region.
ADP 2021 PLWNCDs Proposal _ Meru County
PLWNCD Proposal Pg1
Prevent for the Future: Why Vaccines Matter
September is Childhood Cancer Awareness Month. This September, the Non-Communicable Diseases Alliance Kenya, KILELE Health Association, Kenya Childhood Cancer Trust, Hope for Cancer Kids and Kenyan Network of Cancer Organisations join hands with other cancer control organisations globally to raise awareness on vaccine-preventable cancers: such as cervical and liver cancer. We call upon the government to consider the following measures in eliminating vaccine-preventable cancers: Key Messages 1. The Ministry of Health and County Governments to embark on a promotion campaign to dispel myths and misinformation on vaccines as a strategy for improving uptake of the HPV vaccine amongst girls aged 10 to 12 years. Emphasis should also be laid on the role of the Hepatitis B vaccine in preventing liver cancer. 2. The Ministry of Health and County Governments to strengthen multi-stakeholder collaboration for sustainable vaccination programmes and uptake of vaccines at all levels including school-based programmes. 3. The government to reinforce Media involvement in vaccination programmes especially in dispelling myths and misinformation around HPV and Hepatitis B vaccines. The Media, especially local vernacular radio stations, is a powerful tool for reaching communities with accurate information.
What does Childhood Cancer Diagnosis mean?
September is Childhood Cancer Awareness Month. Cancer is the third leading cause of death in Kenya. It is estimated that 275 children are diagnosed with cancer every month with an average age of a childhood cancer diagnosis between 4 to 6 years old and a survival rate of 19%. This largely can be attributed to late diagnosis and lack of awareness. Treating childhood cancer with radiation and chemotherapy remains one of the biggest challenges due to its lasting, and debilitating effect on children’s bodies. However, the survival rates for childhood cancer can be improved through early detection, and timely treatment. It is important to know the signs and look out for any unusual symptoms such as easy bleeding, swelling of the abdomen or the jaw, weight loss, fever, night sweats, severe headaches, vomiting, limb swelling, pain or unusual fractures. The Ministry of Health, Kenya, needs to set up effective ways of dealing with childhood cancer, under the National Hospital Insurance Fund (NHIF), as childhood cancer treatment is costly. Most of the patients families have to divert financial resources to cover for their medical expenses leading to poverty. The current NHIF oncology package is not enough to cover all costs. The NHIF needs to review the oncology package for a wholistic benefit to the children in accessing treatment.
Opportunity : Researcher Assistant Climate Change Mukuru Project
NCDAK is planning to undertake Knowledge, Attitude, and Practice (KAP) research in Mukuru informal settlement, Nairobi on climate change as a risk factor for NCDs. The research will be done from the first week of September and will involve household interviews using an online line tool/application. NCDAK is accepting applications for a Research Assistant position under a short-term contract. Download the full TOR Here Submission of Applications Interested and qualified persons are invited to submit their Curriculum Vitae detailing the reference list indicating the scope and magnitude of similar assignments and qualifications to careers@ncdak.org not later than August 24, 2021, at 1700hrs (EAT).